Trinity Biotech (TRIB) Interest Coverage Ratio Growth (1y) (2010 - 2024)
Trinity Biotech (TRIB) Interest Coverage Ratio Growth (1y) (2010 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -40.19% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 3.52% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -12.04% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 8.92% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -6.18% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -54.61% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 66.99% |
| 10 | Trinity Biotech | 26,200.00 | -5.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 110.58% |
| Sep 30, 2024 | -56.00% |
| Jun 30, 2024 | -63.22% |
| Mar 31, 2024 | 649.80% |
| Dec 31, 2023 | -52.74% |
| Sep 30, 2023 | -49.36% |
| Jun 30, 2023 | 101.74% |
| Mar 31, 2023 | 1,444.09% |
| Dec 31, 2022 | 1,923.82% |
| Sep 30, 2022 | 283.06% |
| Jun 30, 2022 | -239.46% |
| Mar 31, 2022 | 103.91% |
| Dec 31, 2021 | 97.47% |
| Sep 30, 2021 | 72.80% |
| Jun 30, 2021 | 39,051.13% |
| Mar 31, 2021 | -85.11% |
| Dec 31, 2020 | -535.53% |
| Sep 30, 2020 | -587.72% |
| Jun 30, 2020 | 57.88% |
| Mar 31, 2020 | -29.40% |